Sherry Hikita

Sherry Hikita

Company: Novo Nordisk

Job title: Project Director - Cell Therapy R&D

Seminars:

Defining Considerations when Transitioning Processes & Cell Lines from RUO to GMP 11:00 am

How do we demonstrate comparability when switching cell lines? Key strategies to manage costs associated with transitioning into GMP Optimizing raw material selection to align with GMP standardsRead more

day: Day One Track B Morning

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.